American Century Companies’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
Sell
-15,949
Closed -$139K 1389
2015
Q4
$139K Buy
15,949
+2,671
+20% +$22.5K ﹤0.01% 1286
2015
Q3
$111K Buy
+13,278
New +$211K ﹤0.01% 1328

Other funds holding SRNE

American Century Companies's SRNE Position: Q1 2016 in Review

American Century Companies sold out of Sorrento Therapeutics, Inc. (SRNE) in Q1 2016, closing a stake of 15,949 shares — an estimated $139K sold.

American Century Companies first reported a position in SRNE in Q3 2015 and held it in 2 quarters. The position peaked at $139K in Q4 2015. 68 funds tracked by Wall St. Rank hold SRNE as of Q1 2016.

  • American Century Companies reported no remaining Sorrento Therapeutics, Inc. position as of Q1 2016 after selling out during the quarter.
  • American Century Companies sold 15,949 Sorrento Therapeutics, Inc. shares in Q1 2016, an estimated $139K.
  • American Century Companies first reported a position in Sorrento Therapeutics, Inc. in Q3 2015 and held it in 2 quarters.
  • American Century Companies's Sorrento Therapeutics, Inc. position peaked at $139K in Q4 2015.
  • 68 funds tracked by Wall St. Rank held Sorrento Therapeutics, Inc. as of Q1 2016.

Based on American Century Companies's 13F filing for Q1 2016, filed 2 May 2016.